6 Health Care Provider Stocks to Buy Now

Six health care provider stocks are moving up in their overall rating this week, according to the Portfolio Grader database. Every one of these is graded an “A” (“strong buy”) or “B” overall (“buy”).

Cross Country Healthcare, Inc.’s (CCRN) grade is moving up to a B (“buy”) this week from last week’s C (“hold”). In Portfolio Grader’s specific subcategories of Earnings Momentum, Earnings Surprise and Sales Growth, CCRN also gets A’s. Cross Country Healthcare provides healthcare staffing and outsourcing services to the healthcare market. For more information, get Portfolio Grader’s complete analysis of CCRN stock.

Triple-S Management Corporation Class B (GTS) earns a C this week, jumping up from last week’s grade of A. Triple-S Management is an independent licensee of the Blue Cross Blue Shield Association. For more information, get Portfolio Grader’s complete analysis of GTS stock.

This is a strong week for Fresenius Medical Care AG & Co. KGaA Sponsored ADR (FMS). The company’s rating climbs to B from the previous week’s C. Fresenius Medical Care offers kidney dialysis services and manufactures and distributes equipment and products used in the treatment of dialysis patients. For more information, get Portfolio Grader’s complete analysis of FMS stock.

This week, Bio-Reference Laboratories, Inc. (BRLI) is showing good progress as the company’s rating jumps from a B (“buy”) last week to an A (“strong buy”). Bio-Reference provides laboratory testing services, primarily to customers in the greater New York metropolitan area. For more information, get Portfolio Grader’s complete analysis of BRLI stock.

DaVita HealthCare Partners Inc. (DVA) gets a higher grade this week, advancing from a C last week to a B. DaVita operates kidney dialysis centers in the United States. For more information, get Portfolio Grader’s complete analysis of DVA stock.

HealthEquity Inc (HQY) boosts its rating from a B to an A this week. For more information, get Portfolio Grader’s complete analysis of HQY stock.

Louis Navellier’s proprietary Portfolio Grader stock ranking system assesses roughly 5,000 companies every week based on a number of fundamental and quantitative measures. Stocks are given a letter grade based on their results — with A being “strong buy,” and F being “strong sell.” Explore the tool here.


Article printed from InvestorPlace Media, https://investorplace.com/2015/09/6-health-care-provider-stocks-to-buy-now-ccrn-gts-fms-3/.

©2021 InvestorPlace Media, LLC